Chapter 5

Informed Consent and Patient Autonomy

Patient autonomy—the right to make informed decisions about one's own healthcare—is a cornerstone of modern medical ethics. When AI systems influence clinical decisions, informed consent takes on new dimensions. Patients must understand not only the proposed treatment but also the role algorithms play in their care, what data is used, and what the implications of AI involvement mean for their health outcomes and personal information.

The Foundation of Informed Consent

Informed consent emerged from recognition that patients have the right to determine what happens to their own bodies. This principle, enshrined in law and medical ethics, requires that before any medical intervention, patients receive adequate information to make a voluntary and intelligent choice. The elements of informed consent—disclosure, comprehension, voluntariness, competence, and consent—were developed for human-delivered care. AI challenges each of these elements in new ways.

Traditional informed consent focuses on disclosing the nature of the proposed treatment, its risks and benefits, alternatives, and the consequences of refusing treatment. When AI is involved, the scope of disclosure expands: What role does AI play? How was it trained? What are its limitations? Can the patient opt out? How is their data used? The challenge is providing sufficient information without overwhelming patients or undermining their trust in the care they receive.

AI-Specific Disclosure Requirements

When AI participates in clinical care, patients may need information beyond traditional consent disclosures. The challenge is determining what must be disclosed, how to present complex technical concepts accessibly, and how to integrate AI disclosure into clinical workflows without creating consent fatigue or undermining trust.

Disclosure Element	Traditional Consent	AI-Enhanced Consent	Rationale
Nature of Intervention	What procedure will be performed	AI is involved in diagnosis/treatment decision	Patient right to know who/what influences care
Risks	Medical complications, side effects	AI error rates, performance limitations	AI-specific risks may affect patient decisions
Benefits	Expected health improvements	AI accuracy advantages, consistency	Patients deserve to know potential AI benefits
Alternatives	Other treatment options	Human-only assessment available	Autonomy requires option to decline AI
Data Use	Limited data disclosure	How patient data is processed by AI; storage; sharing	Privacy rights; secondary use implications

What Must Be Disclosed?

There is no consensus on exactly what AI-related information must be disclosed for consent to be valid. Different stakeholders propose varying standards, from minimal disclosure (AI is used) to extensive disclosure (algorithm specifics, training data sources, performance metrics). The appropriate level likely depends on the AI's role, the stakes of the decision, and the patient's preferences.

The Right to Know About AI

A fundamental question in AI ethics is whether patients have a right to know when AI influences their care—even if that knowledge might cause anxiety or change their behavior in ways that affect outcomes. This tension between transparency and potential psychological impact mirrors debates in other disclosure contexts, such as informing patients of incidental findings.

Arguments for Disclosure

• Autonomy: Patients have the right to know what influences their care to make informed decisions
• Trust: Transparency about AI use builds trust; discovering undisclosed AI may undermine it
• Accountability: Disclosure enables patients to seek recourse if AI causes harm
• Dignity: Being subject to algorithmic assessment without knowledge may feel dehumanizing
• Precedent: Medical ethics requires disclosure of material information; AI qualifies

Concerns About Disclosure

• Anxiety: Learning AI is involved may cause unnecessary patient worry
• Nocebo Effect: Negative expectations about AI may worsen outcomes
• Consent Fatigue: Adding AI disclosure to already-lengthy consent processes may reduce comprehension
• Inequitable Burden: Patients with less education may struggle to understand AI information
• Workflow Disruption: Detailed AI explanations may burden clinical encounters

Opt-Out Rights and Alternatives

If AI disclosure is required, should patients have the right to refuse AI-assisted care? The right to opt out raises practical and ethical questions: Is human-only assessment always available? What if AI-assisted care is demonstrably better? How do opt-out requests affect the patient-physician relationship?

Opt-Out Consideration	Patient Perspective	Institution Perspective	Ethical Analysis
Availability	Want meaningful alternative	May be impractical for integrated AI	Autonomy requires genuine choice
Quality Differential	Concern about inferior non-AI care	Liability for worse outcomes without AI	Informed choice includes quality information
Cost Implications	May face higher costs for human-only	Human-only assessment more expensive	Equity concerns if opt-out is costly
Documentation	Want opt-out respected and recorded	Need clear documentation for liability	Process must ensure genuine voluntariness
Workflow Impact	Expect opt-out to be honored smoothly	Disrupts standardized AI workflows	Systems must accommodate patient choice

When Opt-Out May Be Limited

There may be situations where opt-out rights are constrained. If AI is deeply integrated into standard diagnostic equipment, opting out may be impractical. In emergencies, obtaining specific AI consent may be impossible. Resource constraints may limit availability of human-only alternatives. These limitations should be disclosed and justified.

Data Consent for AI Training

Beyond consent for AI-assisted care, patients may need to consent to the use of their data for AI training and development. This secondary use of health data raises distinct ethical considerations about privacy, benefit-sharing, and control over personal information.

Dynamic Consent Models

Traditional one-time consent may be inadequate for ongoing AI development. Dynamic consent models allow patients to make ongoing choices about how their data is used, updated as new AI applications emerge. While more respectful of autonomy, these models are more complex to implement and may create data availability challenges for researchers.

Consent Model	Approach	Advantages	Challenges
Broad Consent	General permission for future research	Simple; enables research	Limited patient control; may not cover novel uses
Specific Consent	Separate consent for each AI project	Precise patient control	Impractical for large datasets; slows research
Tiered Consent	Categories of uses with patient choices	Balances control and practicality	Categories may not match actual uses
Dynamic Consent	Ongoing patient engagement and choices	Continuous autonomy; updated preferences	Technology requirements; engagement burden
Meta-Consent	Consent to governance process rather than specific uses	Scalable; trusts oversight bodies	Indirect patient control; governance quality critical

Vulnerable Populations

Special considerations apply to obtaining consent from vulnerable populations who may face barriers to understanding AI or expressing preferences. Children, elderly patients, those with cognitive impairment, and individuals with limited health literacy require adapted consent approaches.

Implementation Approaches

Integrating AI Consent into Clinical Workflows

Healthcare institutions must develop practical approaches to obtaining AI-related consent that respect patient autonomy while remaining feasible within clinical operations. This requires balancing thoroughness with efficiency.

Consent Documentation

Clear documentation of AI-related consent protects both patients and institutions. Documentation should record what information was provided, patient questions and concerns, the consent decision, and any opt-out requests.

Summary

Review Questions

1. What are the traditional elements of informed consent? How does AI challenge each of these elements?
2. What AI-specific information should be disclosed to patients? Compare minimal, material risk, reasonable patient, and full transparency standards.
3. What arguments support patients' right to know about AI involvement? What concerns might limit or modify this right?
4. Should patients have the right to opt out of AI-assisted care? What limitations on opt-out rights might be justified?
5. How does consent for AI-assisted care differ from consent for data use in AI training?
6. Compare broad consent, specific consent, tiered consent, and dynamic consent models for AI data use. What are the advantages and challenges of each?
7. What special consent considerations apply to vulnerable populations such as children, elderly, and cognitively impaired patients?
8. What practical steps should healthcare institutions take to integrate AI consent into clinical workflows?